A retrospective study on 73 elderly patients (≥75years) with aggressive B-cell non Hodgkin lymphoma: Clinical significance of treatment intensity and comprehensive geriatric assessment

Journal of Geriatric Oncology

Volumn 4, Issue 3, 2013, Pages 242-248

  Marchesi, Francesco ^a   Cenfra, Natalia ^b   Altomare, Lidia ^a   Dessanti, Maria L ^c   Mecarocci, Sergio ^b   Cerchiara, Elisabetta ^a   Rago, Angela ^b   D'Andrea, Mariella ^c   Tomarchio, Valeria ^a   Olimpieri, Odoardo M ^a   Tirindelli, Maria C ^a   Mengarelli, Andrea ^c   Petti, Maria C ^c   Avvisati, Guiseppe ^a   Cimino, Guiseppe ^b  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Aggressive B cell non Hodgkin lymphoma; Anthracyclines based chemotherapy; Comprehensive geriatric assessment; Conservative regimens without anthracyclines; Very elderly patients

Indexed keywords

ANTHRACYCLINE;

AGED; AGING; ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL ASSESSMENT TOOL; COMPREHENSIVE GERIATRIC ASSESSMENT; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DRUG SAFETY; FEMALE; GERIATRIC ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SURVIVAL PREDICTION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTHRACYCLINES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; FRAIL ELDERLY; GERIATRIC ASSESSMENT; HUMANS; LYMPHOMA, B-CELL; MALE; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84878990242     PISSN: 18794068     EISSN: 18794076     Source Type: Journal    
DOI: 10.1016/j.jgo.2013.04.003     Document Type: Article

References (30)

1. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics. CA Cancer J Clin 2010, 60:277-300.
2. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
3. Grulich A.E., Vajdic C.M. The epidemiology of non-Hodgkin lymphoma. Pathology 2005, 37:409-419.
4. Thieblemont C., Coiffier B. Lymphoma in older patients. J Clin Oncol 2007, 25:1916-1923.
5. Thieblemont C., Grossoeuvre A., Houot R., Broussais-Guillaumont F., Salles G., Traullé C., et al. Non-Hodgkin's lymphoma in very elderly patients over 80years. A descriptive analysis of clinical presentation and outcome. Ann Oncol 2008, 19:774-779.
6. The Non-Hodgkin's Lymphoma Classification Project Effect of age on the characteristics and clinical behavior of non-Hodgkin's lymphoma patients. Ann Oncol 1997, 8:973-978.
7. Armitage J.O. Is lymphoma occurring in the elderly the same disease?. Leuk Lymphoma 2008, 49:14-16.
8. Klapper W., Kreuz M., Kohler C.W., Burkhardt B., Szczepanowski M., Salaverria I., et al. Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma. Blood 2012, 119:1882-1887.
9. Peyrade F., Jardin F., Thieblemont C., Thyss A., Emile J.F., Castaigne S., et al. Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80years with diffuse large B-cell lymphoma: a multicenter, single-arm, phase 2 trial. Lancet Oncol 2011, 12:460-468.
10. Feugier P., Van Hoof A., Sebban C., Solal-Celigny P., Bouabdallah R., Fermé C., et al. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Group d'Etude des Lymphomas de l'Adulte. J Clin Oncol 2005, 23:4117-4126.
11. Tirelli U., Carbone A., Monfardini S., Zagonel V. A 20-year experience on malignant lymphomas in patients aged 70 and older at a single institute. Crit Rev Oncol Hematol 2001, 37:153-158.
12. Balducci L., Beghe C. The application of the principles of geriatrics to the management of the older person with cancer. Crit Rev Oncol Hematol 2000, 35:147-154.
13. Balducci L., Extermann M. Management of cancer in the older person: a practical approach. Oncologist 2000, 5:224-237.
14. Parmelee P.A., Thuras P.D., Katz I.R., Lawton M.P. Validation of the cumulative illness rating scale in a geriatric residential population. J Am Geriatr Soc 1995, 43:130-137.
15. Extermann M., Aapro M., Bernabei R., Cohen H.J., Droz J.P., Lichtman S., et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 2005, 55:241-252.
16. Wedding U., Roehrig B., Klippstein A., Steiner P., Schaeffer T., Pientka L., et al. Comorbidity in patients with cancer: prevalence and severity measured by cumulative illness ratin scale. Crit Rev Oncol Hematol 2007, 61:164-171.
17. Extermann M., Hurria A. Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol 2007, 25:1824-1831.
18. Nabhan C., Smith S.M., Helenowski I., Ramsdale E., Parsons B., Karmali R., et al. Analysis of very elderly (≥80years) non-Hodgkin lymphoma: impact of functional status and co-morbidities on outcome. Br J Haematol 2012, 156:196-204.
19. Katz S., Ford A.B., Moskowitz R.W., Jackson B.A., Jaffe M.W. Studies of illness in the aged: the index of ADL-A standardized measure of biological and psychosocial function. JAMA 1963, 185:914-919.
20. Miller M.D., Towers A. A manual of guidelines for scoring the Cumulative Illness Rating for Geriatrics (CIRS-G) 1991, University of Pittsburg, Pittsburg, PA.
21. Tucci A., Ferrari S., Bottelli C., Borlenghi E., Drera M., Rossi G. A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy. Cancer 2009, 115:4547-4553.
22. Cheson B.D., Horning S.J., Coiffier B., Shipp M.A., Fisher R.I., Connors J.M., et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI sponsored international working group. J Clin Oncol 1999, 17:1244.
23. Cheson B.D., Pfistner B., Juweid M.E., Gascoyne R.D., Specht L., Horning S.J., et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007, 25:579-586.
24. Coiffier B., Lepage E., Brière J., Herbrecht R., Tilly H., Bouabdallah R., et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002, 346:235-242.
25. Lee K.W., Kim D.Y., Yun T., Kim D.W., Kim T.Y., Yoon S.S., et al. Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage. Cancer 2003, 98:2651-2656.
26. Advani R.H., Chen H., Habermann T.M., Morrison V.A., Weller E.A., Fisher R.I., et al. Comparison of conventional prognostic indices in patients older than 60years with diffuse large B-cell lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of the age greater than 70years in an elderly prognostic index (E-IPI). Br J Haematol 2010, 151:143-151.
27. Pfreundschuh M., Trümper L., Kloess M., Schmits R., Feller A.C., Rübe C., et al. Two-weekly or 3 weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL. Blood 2004, 104:634-641.
28. + B-cell lymphomas: a randomized controlled trial (RICOVER-60). Lancet Oncol 2008, 9:105-116.
29. Pfreundschuh M., Trümper L., Kloess M., Schmits R., Feller A.C., Rudolph C., et al. Two-weekly or 3 weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL. Blood 2004, 104:626-633.
30. Visani G., Ferrara F., Alesiani F., Ronconi S., Catarini M., D'Adamo F., et al. R-COMP 21 for frail elderly patients with aggressive B-cell non Hodgkin lymphoma: a pilot study. Leuk Lymphoma 2008, 49:1081-1086.